A NEW mRNA cancer vaccine can reprogram the immune system to attack tumours within 48 hours, a study shows.
The first-ever human clinical trial of four adult patients showed the jab helps fight against aggressive and deadly brain tumours.
It uses similar tech to some Covid vaccines to train the immune system and is also personalised to patients using their own DNA.
Dr Elias Sayour, of the University of Florida, said: “I am hopeful that this could be a new paradigm for how we treat patients, a new platform technology for how we can modulate the immune system.
“I am hopeful for how this could now synergize with other immunotherapies and perhaps unlock those immunotherapies.
“We showed that you actually can have synergy with other types of immunotherapies, so maybe now we …